statue of justice

Details on the Actos Settlement

Takeda Pharmaceuticals has agreed to a potential $2.4 billion settlement related to claims that its diabetes drug Actos caused bladder cancer.

Takeda, which does not admit fault as part of the settlement, will pay $2.37 billion in settlements if 95 percent of current litigants agree to the settlement offer. That total will rise to $2.4 billion if 97 percent of litigants opt-in to the settlement.

Takeda has made tens of billions of dollars on Actos, which, ironically, gained popularity as an alternative to Avandia, which can cause cardiovascular issues. While patients were made aware of the fact that Actos also posed a risk of cardiovascular conditions, they were caught by surprise in 2011 when the Food and Drug Administration noted that long-term use of Actos could raise the risk of bladder cancer by as much as 40 percent.

GoldenbergLaw’s drug injury lawyers can answer any questions you might have about the Actos settlement or other dangerous drugs.

GoldenbergLaw handles drug injury cases from across the country. Please call GoldenbergLaw at (800) 504-0281 or contact us online for a free consultation.

Categories

We Truly Care

The GoldenbergLaw Difference
  • Kindness Is Strength.

    With us, you matter most. This team spends the time to ensure clients like you get to rest and leave the sleepless nights to us.

  • Accountability Is Bravery.

    We live and breathe what we do, and we don't stop until the responsible party is held liable.

  • Leadership Is Trust.

    Our firm has been trusted to lead roles within some of the nation's largest litigations.

  • Knowledge Is Power.

    Our firm is focused on the science of the case and applying it to helping our clients recover.

Contact Us

We Focus On What You Need
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.